White House Announces ‘TrumpRx’ Website and Pricing Deal With Pfizer

The White House announced the “TrumpRx” government website and a price reform deal with Pfizer on Tuesday, both of which are aimed at starting drug prices in early 2026. 

TrumpRx: “TrumpRx,” as the website was dubbed, would assist Americans in buying discounted medications. Both CNN (Lean Left bias) and the Wall Street Journal (Center) described TrumpRx as “direct-to-consumer,” but CNN’s article later clarified that the site itself “will not sell or distribute medications” but rather redirect consumers to manufacturers’ “direct-to-consumer channels.” 

Pfizer Deal: Pfizer reportedly agreed to reduce prices of certain drugs (specifically to Medicaid) to “Most Favored Nation” levels, in exchange for a three-year exemption from pharmaceutical tariffs pertaining to US national security. The deal – which follows the Oct. 1 price reduction deadline that President Donald Trump imposed on drug manufacturers last week – also requires Pfizer to invest in US manufacturing. “Most Favored Nation” levels equate to the lowest price available among other wealthy countries (Canada, England, France, Germany, Italy, Japan, Denmark and Switzerland). According to Trump, “similar agreements” with other companies are set to follow.

How The Media Covered It: Coverage of this story was mixed across the political spectrum. CNN noted that Trump “acknowledged” the possibility of increased drug prices in other countries due to the impending reforms, and New York Post (Lean Right) uncharacteristically framed the White House’s announcement negatively by highlighting the uncertainties of the “murky” Pfizer deal. However, the outlet also stated that “the savings for people without insurance are potentially massive.”

Written by the AllSides staff (of humans). Learn more. Support our mission. Suggest an improvement to this summary.